Company profile
TOLREMO therapeutics AG
There is a high unmet need for durable therapeutic options for cancer patients. Although cancer drugs relief patients from their tumor burden, they oftentimes lose their effectiveness over time. TOLREMO develops novel small molecules that eradicate drug resistant cancer cells right at the start of a therapy. TOLREMO’s resistance-breaking add-on therapies can be combined with existing cancer drugs, to meaningfully extend the lives of patients suffering from different types of cancer.MAKING CANCER A MINOR MATTER
Source: startup.ch